Matsumoto Y, Umemura S, Kobayashi N, Tanaka Y, Sasaki C, Shimizu K, Ogawa A, Kinoshita H, Matsuyama Y, Morita T, Goto K, Ohe Y. Early palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening program. 14th World Congress of the European Association for Palliative Care. 5-8 May 2015, Copenhagen, Denmark.
Niikura N, Ohta Y, Hayashi N, Naito M, Kashiwabara K, Watanabe K, Yamashita T, Mukai H, Umeda M. Evaluation of the use of oral care to prevent oral mucositis in estrogen receptor positive metastatic breast cancer patients treated with everolimus: Phase III randomized control trial. At: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX. December 8–12, 2015. Abstr OT1-03-02.
Fukuda T, Shiroiwa T, Simozuma K, Mori M, Doihara H, Akabane H, Kashiwaba M, Watanabe T, Hagiwara Y, Ohashi Y, Mukai H. Long-term EQ-5D score for patients with metastatic breast cancer; comparison of first-line oral S-1 and Taxane therapies in the randomized SLECT trial. International Society for Pharmacoeconomics and Outcome Research 18th Annual European Congress, Milan, Italy, November 9, 2015. Abstract PCN210.
Nomura S, Shinozaki T, Hamada C. Comparison of several approaches to adjust overall survival (OS) for extensive crossovers in placebo-controlled randomized phase 3 trials. At: 36th Annual Conference of the International Society for Clinical Biostatistics, Utrecht, Netherland. Aug 2015. Abstract C25.01.
Shinozaki T, Matsuyama Y. Doubly robust standardization in cohort studies with a binary exposure and censored events. At: 2015 Joint Statistical Meetings, Seattle, WA. Aug 2015. Abstract 316644.
Kobayashi A, Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Bandai Y, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N. A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study. 50th American Society of Clinical Oncology (ASCO) annual meeting.(abstract 3584). May 30-June 3, 2014, McCormick Place, Chicago, Illinois.
Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Matsuyama Y, Nanto S. J-DESsERT 3-Year Outcomes: Largest randomized trial stratified by diabetes mellitus presence, comparing sirolimus and paclitaxel eluting stents. Transcatheter Cardiovascular Therapeutics (TCT). October 27-November 1, 2013, The Moscone Center San Francisco, CA, USA.
Naito Y, Ohashi Y, Yokota I, Watanabe T, Iwata H, Ohsumi S, Ohno S, Hozumi Y, Yamamoto S, Takahashi M, Aihara T, Mukai H. Low body mass index (BMI) is associated with poor survival in Japanese patients with early breast cancer; an exploratory analysis of prospective randomized phase III trials N-SAS BC02 and 03. 2014 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 13, 2014. Session # P6-08-21.
Nomura S, Shinozaki T, Hamada C. A new framework using g-estimation for placebo-controlled randomized phase 3 trials with extensive crossovers for biomarker-driven molecularly targeted oncology agents. 35th Annual Conference of the International Society for Clinical Biostatistics, Vienna, Austria. Aug 2014. Abstract C.25.5.
Shinozaki T, Matsuyama Y. Robust and efficient estimation of structural nested mean models in randomized trials with partial compliance using generalized method of moments. The XXVIIth International Biometric Conference, Florence, Italy. July 10, 2014. Poster Group 2, Abstract 35.
Yoshimura A, Iwata H, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Toyama T. A randomized phase II study evaluating the use of prydoxine to prevent hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer. 2014 ASCO annual meeting, Chicago, IL, Jun 1, 2014. J Clin Oncol 32:5s, 2014 (suppl; abstr 9610).
Ohtani S, Masuda N, Im Y-H, Im S-A, Park B-W, Kim S-B, Yanagita Y, Takao S, Ohno S, Aogi K, Iwata H, Yoshidome K, Nishimura R, Lee E-S, Yokota I, Ohashi Y, Lee S-J, Toi M. Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy : First safety analysis of CREATE-X (JBCRG-04). 2013 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 12, 2013. Session # P3-12-03.
Yokoyama T, Kunikane H, Katakami N, Yokota I, Saito Y, Shimozuma K, Ohashi Y, Eguchi K. A prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). European Cancer Congress 2013 (ESMO38), Amsterdam, Netherlands, Sep 30, 2013. Abstract # P130.
Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.
Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.